Literature DB >> 20935679

Srg3, a mouse homolog of BAF155, is a novel p53 target and acts as a tumor suppressor by modulating p21(WAF1/CIP1) expression.

J Ahn1, M Ko, C Lee, J Kim, H Yoon, R H Seong.   

Abstract

Some subunits of the SWI/SNF complex function as tumor suppressors. However, underlying mechanisms are still incompletely defined. Here, we show that Srg3, a mouse homolog of BAF155 that function as a core subunit of this complex, suppresses tumorigenesis in vivo. DNA damage signals promoted Srg3 degradation by inducing p53. Deficiency of Srg3 promoted G1 cell-cycle arrest, but antagonized apoptotic response to DNA damage by robustly inducing p53 and p21 proteins. Srg3 heterozygous mice were prone to sarcoma formation, which was further enhanced by haploinsufficiency of p53. These tumors highly expressed p53 and p21 but lacked Srg3 expression. Our results establish a novel function of Srg3 in tumor suppression and provide insights into genetic pathways dictating tumor suppression by the SWI/SNF complex.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20935679     DOI: 10.1038/onc.2010.424

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

Review 1.  The dynamic interplay in chromatin remodeling factors polycomb and trithorax proteins in response to DNA damage.

Authors:  Shuang Liu; Yongguang Tao; Xiang Chen; Ya Cao
Journal:  Mol Biol Rep       Date:  2011-12-28       Impact factor: 2.316

2.  RBM15 Modulates the Function of Chromatin Remodeling Factor BAF155 Through RNA Methylation in Developing Cortex.

Authors:  Yuanbin Xie; Ricardo Castro-Hernández; Godwin Sokpor; Linh Pham; Ramanathan Narayanan; Joachim Rosenbusch; Jochen F Staiger; Tran Tuoc
Journal:  Mol Neurobiol       Date:  2019-04-24       Impact factor: 5.590

Review 3.  SWI/SNF chromatin remodeling complexes and cancer.

Authors:  Jaclyn A Biegel; Tracy M Busse; Bernard E Weissman
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-08-28       Impact factor: 3.908

4.  The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner.

Authors:  Daniel W Serber; Allison Rogala; Maisam Makarem; Gary B Rosson; Karl Simin; Virginia Godfrey; Terry Van Dyke; Connie J Eaves; Scott J Bultman
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

5.  miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1.

Authors:  Y Iwagami; H Eguchi; H Nagano; H Akita; N Hama; H Wada; K Kawamoto; S Kobayashi; A Tomokuni; Y Tomimaru; M Mori; Y Doki
Journal:  Br J Cancer       Date:  2013-06-25       Impact factor: 7.640

6.  Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination.

Authors:  Lee F Langer; James M Ward; Trevor K Archer
Journal:  Elife       Date:  2019-04-29       Impact factor: 8.140

7.  GBAF, a small BAF sub-complex with big implications: a systematic review.

Authors:  Sarah M Innis; Birgit Cabot
Journal:  Epigenetics Chromatin       Date:  2020-11-03       Impact factor: 4.954

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.